The Patent Finder
US

Multimeric Oligonucleotides Compounds Having Cleavable Linkers

US 9,732,340 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Sep 14, 2032 · Low confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Apr 28, 2015 as application 14/698,239 · Granted Aug 15, 2017
Base term, 20 years from filing
Today
20 years from filing
2012 2032
Clock starts
Sep 14, 2012
Ends no later than
Sep 14, 2032
Granted
Aug 15, 2017
base term fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 14, 2012, when application PCT/US2012/055535, the earliest non-provisional in its chain, was filed (this one was filed Apr 28, 2015); a parent in its chain could not be resolved (the next row)Sep 14, 2032High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Sep 14, 2032Low confidence

Partial family

Application PCT/US2012/055535PCT application
no patent term
no patent term
US 9,580,708In force
Sep 2032
Sep 2032
US 9,732,340this patent
no later than Sep 2032
no later than Sep 2032
US 9,732,341In force
no later than Sep 2032
no later than Sep 2032
US 10,093,924In force
no later than Sep 2032
no later than Sep 2032
US 10,704,046In force
no later than Sep 2032
no later than Sep 2032
Partial: 1 of the 6 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 10, 2016
Reel 40276, frame 664
Subramanian, RomeshPfizer Inc.Assignment of Assignor's Interest
Nov 10, 2016
Reel 40276, frame 731
Rockel, Thomas Dino; Uhlmann, Eugen; Weber, MarkusColey Pharmaceutical GmbHAssignment of Assignor's Interest
Nov 10, 2016
Reel 40276, frame 784
Pfizer Inc.; Coley Pharmaceutical GmbHRana Therapeutics, Inc.Assignment of Assignor's Interest
Nov 10, 2016
Reel 40586, frame 659
Uhlmann, Eugen; Subramanian, Romesh; Krieg, Arthur M.Rana Therapeutics, Inc.Assignment of Assignor's Interest
Jun 14, 2017
Reel 42806, frame 864
Rana Therapeutics, Inc.Rana Development, Inc.Change of Name
Jun 28, 2017
Reel 43027, frame 36
Rana Development, Inc.Translate Bio Ma, Inc.Change of Name
Jul 7, 2017
Reel 43114, frame 947
Rana Development, Inc.Translate Bio Ma, Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited